Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /
The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Korporativna značnica: | |
| Format: | Elektronski eKnjiga |
| Jezik: | English |
| Izdano: |
Heidelberg :
Physica-Verlag HD : Imprint: Physica,
2006.
|
| Izdaja: | 1st ed. 2006. |
| Serija: | Contributions to Management Science,
|
| Teme: | |
| Online dostop: | https://doi.org/10.1007/3-7908-1668-X |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Kazalo:
- Key Issues in Managing Pharmaceutical Innovation
- Risk-sharing as New Paradigm in Pharma R&D Collaborations
- Case Studies on Risk-sharing in Pharma R&D Collaborations
- Characteristics of Risk-sharing in Pharma R&D Collaborations
- Theoretical Basis for Risk-sharing in Pharma R&D Collaborations
- Managerial Recommendations for Risk-sharing in Pharma R&D Collaborations
- Conclusion.